/u/Front-Page_News's posts
NRx Pharmaceuticals (NASDAQ:NRXP) to Proceed with Two New Drug Applications in 2024; NRX-101 has Been Returned to the Company for Filing
Mark as read: Add to a list
Mark as read: Add to a list
CYCA Cytta Corp. Sees Skyrocketing Law Enforcement Interest in CyttaCOMMS Following Groundbreaking AI-Enhanced Marketing Campaign in Florida
Mark as read: Add to a list
Mark as read: Add to a list
IFUS Impact Fusion International Inc. Announces the Commencement of a Research Project with Southern University Agricultural and Research Center (SUARC)
Mark as read: Add to a list
Mark as read: Add to a list
NRXP - New Drug Application (NDA) for Accelerated Approval planned for NRX-101 in people with bipolar depression and akathisia in 2024, based on two positive trials 1 2 and Breakthrough Therapy Designation. Potential revenue in 2025
Mark as read: Add to a list
CATV - Financial Audit Initiatives Update: In our relentless pursuit of excellence, we have initiated the process of selecting an auditor for a thorough financial audit.
Mark as read: Add to a list